Three patients developed a Fanconi syndrome with impairment of glomerular function (endogenous creatinine clearance 30–60 ml/min per 1.73 m2) during and/or after treatment with ifosfamide according to the SIOP-MMT 84 protocol in which ifosfamide was given in a dose of 3000 mg/m2 every 4 weeks over a 10-month period. The need for early substitution therapy in patients with the Fanconi syndrome is stressed. The renal lesions in our patients were irreversible.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
- MMT 84:
malignant mesenchymal tumours 1984
ifosfamide, vincristine, actinomycin D
Brodehl J (1978) The Fanconi syndrome. In: Edelmann CM Jr (ed) Pediatric kidney disease. Little Brown, Boston, pp 955–987
Brunat-Mentigny M, Dutou L, Flamant F, Olive D, Otten J, Quintana E, Rodary C, Voute PA, Cailland JM, Marsden M, Unnik A van (1984) Protocol for the treatment of malignant mesenchymal tumours in children. SIOP (Societé Internationale d'Oncologie Pediatrique)
Ghazali S, Barratt T (1974) Urinary excretion of calcium and magnesium in children. Arch Dis Child 49:97–101
Heim ME, Fiene R, Schick E, Wolpert E, Queiber W (1981) Central nervous system side effects following ifosfamide monotherapy of advanced renal carcinoma. J Cancer Res Clin Oncol 100:113–116
Hilgard P, Burkert H (1984) Sodium-2-mercapto-ethanesulfonate (MESNA) and ifosfamide nephrotoxicity. Eur J Cancer Clin Oncol 20:1451–1452
Ingelfinger JR (1987) Persistent renal-genitourinary disorders. Nijhoff, Boston, pp 95–109
Kehl A, Bergholz M, Heyden HW von, Nagel G-A (1983) Toxisch allergisches Lungenödem nach Cyclophosphamid-und Ifosfamid Therapie. Onkologie 6:84–86
Kreusser W, Herrmann R, Tschöpe W, Ritz E (1982) Nephrological complications of cancer therapy. Contrib Nephrol 33:223–238
Kruse K, Kracht U, Göpfert G (1982) Renal threshold phosphate concentration (TmPO4/GFR). Arch Dis Child 57:217–223
Monnens L, Smulders Y, Lier H van, Boo T de (1981) DDAVP test for assessment of renal concentrating capacity in infants and children. Nephron 29:151–154
Ries F, Klasterysky J (1986) Nephrotoxicity induced by cancer chemotherapy with special emphasis to cisplatin toxicity. Am J Kidney Dis 8:368–379
Sangster G, Kaye SB, Calman KC, Dalton JF (1984) Failure of 2-mercaptoethane sulphonate sodium (Mesna) to protect against ifosfamide nephrotoxicity. Eur J Cancer Oncol 20:435–436
Schärer K (1980) Nephrotoxic action of immunosuppressive and cytostatic agents. Helv Paediatr Acta 41:103–104
About this article
Cite this article
Smeitink, J., Verreussel, M., Schröder, C. et al. Nephrotoxicity associated with ifosfamide. Eur J Pediatr 148, 164–166 (1988). https://doi.org/10.1007/BF00445929
- Fanconi syndrome
- Disturbances of glomerular filtration